136 related articles for article (PubMed ID: 3678736)
1. Benign recurrent intrahepatic cholestasis. Evidence for an intrinsic abnormality in hepatocyte secretion.
Minuk GY; Shaffer EA
Gastroenterology; 1987 Dec; 93(6):1187-93. PubMed ID: 3678736
[TBL] [Abstract][Full Text] [Related]
2. Cholestatic liver diseases: slow progress in understanding and treating slowly progressive disorders.
Vleggaar FP; Van Ooteghem NA; Van Buuren HR; Van Berge Henegouwen GP
Scand J Gastroenterol Suppl; 2000; (232):86-92. PubMed ID: 11232499
[TBL] [Abstract][Full Text] [Related]
3. Extracorporal albumin dialysis (MARS) improves cholestasis and normalizes low apo A-I levels in a patient with benign recurrent intrahepatic cholestasis (BRIC).
Sturm E; Franssen CF; Gouw A; Staels B; Boverhof R; De Knegt RJ; Stellaard F; Bijleveld CM; Kuipers F
Liver; 2002; 22 Suppl 2():72-5. PubMed ID: 12220310
[TBL] [Abstract][Full Text] [Related]
4. The pathophysiology of cholestasis with special reference to primary biliary cirrhosis.
Jansen PL
Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):571-83. PubMed ID: 10976015
[TBL] [Abstract][Full Text] [Related]
5. Benign recurrent intrahepatic cholestasis: altered bile acid metabolism.
Bijleveld CM; Vonk RJ; Kuipers F; Havinga R; Boverhof R; Koopman BJ; Wolthers BG; Fernandes J
Gastroenterology; 1989 Aug; 97(2):427-32. PubMed ID: 2744357
[TBL] [Abstract][Full Text] [Related]
6. A distinctive pattern of serum bile acid and bilirubin concentrations in benign recurrent intrahepatic cholestasis.
Summerfield JA; Kirk AP; Chitranukroh A; Billing BH
Hepatogastroenterology; 1981 Jun; 28(3):139-42. PubMed ID: 7250892
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of hepatobiliary transport systems in health and disease: implications for a rationale approach to the treatment of intrahepatic cholestasis.
Wagner M; Trauner M
Ann Hepatol; 2005; 4(2):77-99. PubMed ID: 16010241
[TBL] [Abstract][Full Text] [Related]
8. [Benign recurrent intrahepatic cholestasis type-II--a rare cause of direct hyperbilirubinemia exacerbations with hepatic fibrosis].
Mizrahi M; Lalazar G; Horwich Y; Adar T; Safadi R
Harefuah; 2008 May; 147(5):381-3, 480. PubMed ID: 18770956
[TBL] [Abstract][Full Text] [Related]
9. The effect of complete biliary obstruction on bile flow and bile acid excretion: postcholestatic choleresis in the rat.
Accatino L; Contreras A; Fernańdez S; Quintana C
J Lab Clin Med; 1979 May; 93(5):706-17. PubMed ID: 429869
[TBL] [Abstract][Full Text] [Related]
10. Hepatic handling of bile salts and protein in the rat during intrahepatic cholestasis.
Goldsmith MA; Huling S; Jones AL
Gastroenterology; 1983 May; 84(5 Pt 1):978-86. PubMed ID: 6832571
[TBL] [Abstract][Full Text] [Related]
11. Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment.
Ramm GA; Shepherd RW; Hoskins AC; Greco SA; Ney AD; Pereira TN; Bridle KR; Doecke JD; Meikle PJ; Turlin B; Lewindon PJ
Hepatology; 2009 Feb; 49(2):533-44. PubMed ID: 19115220
[TBL] [Abstract][Full Text] [Related]
12. Nasobiliary drainage induces long-lasting remission in benign recurrent intrahepatic cholestasis.
Stapelbroek JM; van Erpecum KJ; Klomp LW; Venneman NG; Schwartz TP; van Berge Henegouwen GP; Devlin J; van Nieuwkerk CM; Knisely AS; Houwen RH
Hepatology; 2006 Jan; 43(1):51-3. PubMed ID: 16374853
[TBL] [Abstract][Full Text] [Related]
13. [Bile formation and cholestasis].
Jansen PL; Müller M; Kuipers F
Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2384-91. PubMed ID: 11145092
[TBL] [Abstract][Full Text] [Related]
14. Progressive familial intrahepatic cholestasis and benign recurrent intrahepatic cholestasis: a review.
Strubbe B; Geerts A; Van Vlierberghe H; Colle I
Acta Gastroenterol Belg; 2012 Dec; 75(4):405-10. PubMed ID: 23402083
[TBL] [Abstract][Full Text] [Related]
15. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.
Crosignani A; Podda M; Bertolini E; Battezzati PM; Zuin M; Setchell KD
Hepatology; 1991 Jun; 13(6):1076-83. PubMed ID: 2050325
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional alterations of hepatocytes during transient phalloidin-induced cholestasis in the rat.
Loranger A; Barriault C; Yousef IM; Tuchweber B
Toxicol Appl Pharmacol; 1996 Mar; 137(1):100-11. PubMed ID: 8607135
[TBL] [Abstract][Full Text] [Related]
17. Effect of maternal cholestasis on biliary lipid and bile acid secretion in the infant rat.
El-Mir MY; Monte MJ; Morales AI; Arevalo M; Serrano MA; Marin JJ
Hepatology; 1997 Sep; 26(3):527-36. PubMed ID: 9303479
[TBL] [Abstract][Full Text] [Related]
18. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat.
Koopen NR; Wolters H; Havinga R; Vonk RJ; Jansen PL; Müller M; Kuipers F
Hepatology; 1998 Feb; 27(2):537-45. PubMed ID: 9462655
[TBL] [Abstract][Full Text] [Related]
19. A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis.
Stindt J; Ellinger P; Weissenberger K; Dröge C; Herebian D; Mayatepek E; Homey B; Braun S; Schulte am Esch J; Horacek M; Canbay A; Schmitt L; Häussinger D; Kubitz R
Liver Int; 2013 Nov; 33(10):1527-35. PubMed ID: 23758865
[TBL] [Abstract][Full Text] [Related]
20. Effect of cholestasis on hepatic transport of 99mtechnetium p-isopropyl-iminodiacetic acid.
Knodell RG; Shafer RB; Stanley LN; Goodman M; Elson MK
J Lab Clin Med; 1984 Oct; 104(4):517-27. PubMed ID: 6481215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
